Aetna and Quest to rationalise contracts:
This article was originally published in Clinica
Aetna US Healthcare has formed a new contract with Quest Diagnostics. This replaces multiple contracts between Aetna, Quest and SmithKline Beecham Clinical Laboratories, which was bought by Quest last August. Quest Diagnostics is to provide laboratory services to Aetna US Healthcare members from April 1. Teterboro, New Jersey-based Quest has a network of over 40 major laboratories and 1,400 patient service centres.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.